The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Conditions
- Acute Lymphoblastic Leukemia
- Lymphoma
- Multiple Myeloma
Interventions
- BIOLOGICAL: CAR-T Autologous T cell injection
Sponsor
Hebei Senlang Biotechnology Inc., Ltd.
Collaborators